Cancer
Top Stories
-
Columbia cell therapy pioneer Michel Sadelain has received the 2025 Merkin Prize in Biomedical Technology and the 2025 King Faisal Prize in Medicine.
Topic
-
Columbia researchers are uncovering potential new therapies to counter the changing identities of cancer cells.
Topic
-
Columbia cancer researcher Cory Abate-Shen has been elected to the National Academy of Sciences, one of science’s highest honors.
Topic
-
A new Columbia study shows that increased screening for Lynch Syndrome—an inherited condition linked to several types of cancer—could reduce deaths from colon cancer in at-risk persons by nearly 80%.
Topic
Latest News
- March 7, 2022
Having a rapport with kids is a critical part of the job for James Church and other Columbia colorectal surgeons who treat people with hereditary colon cancer.
Topic
- March 3, 2022
Lung cancer often spreads to the brain. Columbia scientists have now uncovered a tactic used by metastases to hide in the brain and identified a drug combination that can potentially target them.
Topic
- February 22, 2022
By applying artificial intelligence to standard-of-care imaging, Columbia cancer researchers can predict how well immunotherapy will work for patients with melanoma.
Topic
- February 4, 2022
A clinical trial led by a Columbia neuro-oncology team suggests that a new type of anti-cancer drug has promise for patients with glioblastoma.
- January 27, 2022
Active surveillance has emerged as a safe option for some thyroid cancers, illustrating that less can be more in thyroid cancer management.
- January 25, 2022
Columbia cancer researchers are developing virtual reality technology to visualize and explore cancer tumors and gain new insights.
- January 24, 2022
Barbara Pro, MD, a leader in lymphoma research and care, has been named clinical director of the lymphoma program at Columbia University's Herbert Irving Comprehensive Cancer Center.
- January 19, 2022
New Columbia research suggests that targeting neighboring bone cells may be a better strategy than targeting malignant stem cells to treat acute myeloid leukemia.
Topic
- January 11, 2022
In the face of daunting disparities in health care, the medical community can take small steps that make a difference, a Columbia orthopedic surgeon writes.
Topic
- December 23, 2021
The National Cancer Act, signed into law Dec. 23, 1971, funded the expansion of cancer research and care at Columbia. Today, with plans for a new clinical building, the future looks bright.
Topic
